Cambridge Enterprise Unveils "Leaps": A Strategic Initiative for Deeptech

Cambridge Enterprise, the commercialization arm of the University of Cambridge, has announced the launch of "Leaps," a new initiative designed to integrate Cambridge-based deeptech companies into complementary global ecosystems. The primary goal is to provide selected founders with privileged access to new markets, talent, and investment opportunities in key geographical hubs, thereby accelerating their path to success.

The first phase of this ambitious initiative is the "London Leap," inaugurated in collaboration with prominent international partners: Phoenix Court, Balderton Capital, and the BioInnovation Institute Foundation (BII). This London hub will offer space for three companies, allowing Cambridge startups to immerse themselves in the dynamic ecosystem of the British capital, renowned for attracting international capital and its consistent ability to generate unicorn companies.

The Synergy Between Innovation and Global Markets

Cambridge is globally recognized as a leading innovation center. According to the Ecosystem Index, the city ranks among the top worldwide for innovation output per capita, surpassed only by the Bay Area and Boston. This deep connection with London is strategic, as it unites two powerful and complementary ecosystems, creating an essential bridge for companies seeking to scale internationally.

The "Leaps" initiative aims to empower Cambridge-born companies by translating world-renowned research conducted at the University of Cambridge into concrete commercial solutions. This research addresses some of the major global challenges, including climate health, human health, and quantum computing. Since 1995, companies supported by Cambridge Enterprise have collectively raised over £4.9 billion, solidifying Cambridge's reputation as a trusted source of science-based commercial innovation.

Objectives and Selection Mechanisms

The "Leaps" initiative goes beyond providing physical space; it aims to forge meaningful connections that enable companies to grow and thrive. Jim Glasheen, CEO of Cambridge Enterprise, emphasized that companies cannot grow and scale in isolation, and London, as a globally connected hub, represents an ideal starting point. The "Leaps" partners will help companies integrate as "local players" within these innovative ecosystems.

Interested companies will be invited to apply and will be selected on a competitive basis. The selection will be made by the "Leaps" partners and an advisory board composed of investors and serial entrepreneurs with a global presence. Members of this board include prominent figures such as Susan Hill (CEO of Mestag Therapeutics), Daniel Mahony (Senior Partner at Novo Holdings UK), Lord David Prior (Deputy Chairman UK and Global Senior Advisor at Lazard), Dr. Bobby Yerramilli-Rao (Chief Strategy Officer at Microsoft), and Dr. Kaja Wasik (CEO of Echo Labs).

Future Prospects and Impact on the Deeptech Landscape

The "London Leap" is merely the beginning of a broader vision. Jim Glasheen anticipates that Cambridge Enterprise intends to identify new ecosystems in different locations, continuing to build a global proposition for "Leaps." This expansion aims to replicate the success of the London model, extending the reach and influence of Cambridge's deeptech startups.

Suranga Chandratillake, General Partner at Balderton, highlighted how Cambridge continues to be one of the most dynamic ecosystems for deeptech, producing successful companies like Wayve, Healx, and Darktrace. Julia Hawkins, General Partner at Phoenix Court, added that the current opportunity is to help more of these companies connect earlier with global markets, talent, and customers, and London offers the density of operators, investors, and international networks necessary to accelerate this journey. Jen Nielsen, CEO of the BioInnovation Institute, concluded by reiterating the commitment to transforming excellent scientific research into commercially viable companies, recognizing Cambridge as a hub of scientific excellence and entrepreneurial talent.